Background: Completed human papillomavirus (HPV) vaccination by age 16 years among women in Switzerland ranges from 17 to 75% across 26 cantons. The consequences of regional heterogeneity in vaccination coverage on transmission and prevalence of HPV-16 are unclear. Methods: We developed a deterministic, population-based model that describes HPV-16 transmission among young adults within and between the 26 cantons of Switzerland. We parameterized the model using sexual behavior data from Switzerland and data from the Swiss National Vaccination Coverage Survey. First, we investigated the general consequences of heterogeneity in vaccination uptake between two sub-populations. We then compared the predicted prevalence of HPV-16 resulting from heterogeneous HPV vaccination uptake in all of Switzerland with homogeneous vaccination at an uptake that is identical to the national average (52%). Results: In our baseline scenario, HPV-16 prevalence in women is 3.34% when vaccination is introduced and begins to diverge across cantons, ranging from 0.19 to 1.20% after 15 years of vaccination. After the same time period, overall prevalence of HPV-16 in Switzerland is only marginally higher (0.63%) with heterogeneous vaccination uptake than with homogeneous uptake (0.59%). Assuming inter-cantonal sexual mixing, cantons with low vaccination uptake benefit from a reduction in prevalence at the expense of cantons with high vaccination uptake. Conclusions: Regional variations in uptake diminish the overall effect of vaccination on HPV-16 prevalence in Switzerland, but the effect size is small. Cantonal efforts towards HPV-prevalence reduction by increasing vaccination uptake are impaired by cantons with low vaccination uptake. Although the expected impact on national prevalence would be relatively small, harmonization of cantonal vaccination programs would reduce inter-cantonal differences in HPV-16 prevalence.
Introduction
Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) of the reproductive tract [1] . Persistent infections with HVP types 16 and 18 are responsible for 70% of cervical cancers and precancerous cervical lesions [1] . In Switzerland, around 250 new cases of cervical cancer and some 5000 cases of precancer have been diagnosed each year, with cervical cancer being the fifth most frequent type of cancer among women aged 20 to 49 years [2] . The first vaccine against human papillomavirus (HPV) was licensed in 2006 and is now widely used in many countries. At the population-level, HPV vaccination has led to a substantial reduction in the prevalence of the targeted oncogenic HPV types (HPV-16/18) and of anogenital warts [3] . Most vaccination programs target girls or young women before they become sexually active. Regional differences in vaccination uptake have emerged in some countries after implementation of the vaccination programs [4, 5] . These differences are very pronounced in Switzerland where the proportion of 16 year old girls completing the three dose vaccination schedule ranges from 17 to 75% in 26 cantons (states) (Fig. 1) [6, 7] . The cantonal heterogeneity in vaccination uptake can be partly explained by differences in the way the vaccine is offered to girls and young women (e.g., school-based programs, general practitioners or gynecologists). Other factors, such as cultural differences between the cantons might play a role too. To date, the potential epidemiological consequences of regional variation in vaccination uptake on transmission and prevalence of HPV in Switzerland and other countries are not well understood.
Mathematical models have played an important role in estimating the expected impact of vaccination on the transmission of HPV [8] [9] [10] and other infections [11] . Investigating the consequences of spatial heterogeneity in vaccination uptake has received less attention, with some exceptions. Studies on measles vaccination [12, 13] and canine rabies [14] showed that spatial vaccination heterogeneity leads to less effective control of the targeted disease when compared with homogeneous vaccination. The debate about heterogeneity in HPV vaccination uptake has focused on sexspecific vaccination [15] [16] [17] . For the extreme case where only one sex is fully vaccinated, although coverage would be 50% of the total population, the transmission would be completely blocked as the vaccine-targeted sex would act as a dead-end host. Assuming a fixed unit price per vaccine dose and without considering further marginal costs of vaccine distribution, sex-specific vaccination is often considered to be more beneficial than homogeneous (male/female) vaccination in a heterosexual population [15] [16] [17] . In contrast, spatial heterogeneity in vaccination uptake is expected to have a different impact on transmission compared to sex-specific heterogeneity, as transmission can continue independently in spatial sub-populations with low vaccination uptake. Spatial variation in HPV vaccination uptake between states in the United States of America (USA) has been taken into account in a modeling study that quantified the epidemiological impact and cost-effectiveness of adopting a new, nonavalent HPV vaccine [18] . This study suggested that expanding vaccination coverage in states with low coverage would result in the greatest health impact because of the decreasing marginal returns of herd immunity. This finding is supported by another modeling study from Canada showing that the effect of unequal vaccination uptake among school girls by ethnicity on cervical cancer incidence may be lower than with equal vaccination [19] . The effects of spatial heterogeneity in vaccination uptake crucially depend on sexual mixing between different regions, as well as herd immunity thresholds and other disease-specific characteristics. A better understanding of how these factors affect the transmission and prevalence of HPV may help to better interpret the expected or observed impact of HPV vaccination programs.
The aim of this study was to investigate the impact of heterogeneous vaccination uptake and different sexual mixing scenarios on the prevalence of HPV-16 in Switzerland. We developed a mathematical model of HPV-16 transmission among young heterosexual adults. We parameterized the model using Swiss sexual behavior data and calculated the pre-vaccination prevalence and the basic reproduction number (R 0 ) of HPV-16. First, we investigated the general consequences of heterogeneous vaccination uptake in a simple model with two sub-populations. We then simulated the transmission of HPV-16 within and between the 26 cantons of Switzerland assuming three different scenarios for inter-cantonal sexual mixing. We compared the predicted post-vaccination prevalence of HPV-16 after the introduction of heterogeneous HPV vaccination uptake with a default scenario of homogeneous vaccination. (Fig. S1 ).
Methods

HPV-16 transmission model
We developed a deterministic, population-based model of HPV transmission, based on well-established work on modeling STIs [20] [21] [22] . For simplicity, we focused on HPV-16 only as it is the most common oncogenic type in women worldwide [23] and responsible for more than 50% of invasive cervical cancers [24] . We implemented the spatial (cantonal) structure into a metapopulation model, and considered the population of 18-24 year old heterosexual Swiss adults who can be susceptible (S), infected (I), recovered (R) or vaccinated (V). These compartments are further divided into sub-compartments that reflect the individuals' sex, sub-population/canton and sexual activity level, and can be described by the following system of ordinary differential equations (ODEs):
Here, the subscripts s; k and r denote sex, sub-population/ canton and sexual activity group, respectively. Susceptible individuals (S) can become infected at rate k skr (force of infection).
Infected individuals (I) spontaneously clear HPV-16 at rate c to become temporarily immune. Recovered individuals (R) lose their immunity at rate x and become susceptible again. All individuals enter and leave the population at rate l with N skr ¼ S skr þ I skr þ R skr þ V skr being the population size of individuals that have sex s, reside in sub-population/canton k and belong to sexual activity group r. p sk is the sub-population-or cantonspecific proportion of individuals that are vaccinated upon entering the population, with v e being the vaccine efficacy. We assumed that vaccine protection lasts for an individual's sexual lifetime. Finally, heterogeneity in sexual activity can occur at the individual level as well as between activity classes [25] . We assume that individuals can change their sexual behavior at rate m, i.e., they are redistributed to either the same or another sexual activity group proportional to the size of the target group, n r [22, 26] .
Data and parameters
Vaccination uptake
We used data from the Swiss National Vaccination Coverage Survey (SNVCS) to obtain the proportion of women who are vaccinated in each canton (Fig. 1, Supplementary Material Table S1 ). The SNVCS monitors immunization coverage of children and adolescents and compiles them into three-year bands. For HPV vaccination, the surveys focus on 16 years old girls only. In this study, we used data from the last available survey period (2011) (2012) (2013) 95% of vaccinated women received the quadrivalent vaccine [6] . We used the proportion of fully vaccinated women (completed three doses) as a model parameter. Although Switzerland adopted the two-dose HPV vaccination schedule in 2012, we assumed that this had not been implemented in the cantonal programs at the time the surveys were done. We did not consider HPV vaccination in boys and young men, as uptake in Switzerland was negligible before 2016.
Sexual behavior
We used data from the SIR (Screening, Impfung und Risikofaktoren) survey [6] . The Swiss Federal Office of Public Health (FOPH) conducted this survey in 2014 and collected data on the sexual behavior of 18-24 year old Swiss women (n ¼ 1291). We categorized the study participants into two sexual activity groups and estimated the sexual partner change rates by assuming that the distribution of the reported numbers of new heterosexual partners in the last year can be modeled as a mixture of two Poisson distributions, weighted by the proportion of individuals in each sexual activity group [27, 22] . The survey did not include men, so we assumed their sexual activity to be the same as for women. Furthermore, we assumed that sexual behavior does not differ between cantons.
Inter-cantonal mixing
We used mobility data from the Swiss Federal Office for Spatial Development as a proxy for sexual mixing between different cantons. The data set contains average daily commuting data by public transport and individual vehicles from Monday to Friday in 2010 [28] .
Other parameters
We used publicly available data about the number of 18-24 year olds in each canton in 2013 from the website of the Swiss Federal Statistical Office [29] (Supplementary Material Table S2 ). Parameters that describe the transmission and natural-history of HPV-16 were informed by the literature [30, 31] and assumed to be the same for women and men. All parameter values and their sources are specified in Table 1 .
Sexual mixing and force of infection
In our model, the force of infection, k skr , depends on assumptions about sexual contact preferences between individuals from different sexual activity groups and sub-populations/cantons. We devised three different scenarios of increasing complexity to account for different spatial mixing patterns ( Fig. 2 ):
1. Assortative sexual mixing: Sexual contacts only occur between individuals from the same sub-population/canton. 2. Proportional sexual mixing: A fraction of sexual contacts occur between individuals from the same sub-population/canton, while the remaining contacts are proportionally distributed across all sub-populations/cantons. 3. Mobility-informed sexual mixing: Swiss mobility data are used as a proxy for inter-cantonal sexual mixing.
Assortative and proportional sexual mixing
In the first two scenarios, where we assumed fully assortative or partial proportional mixing between sub-populations/cantons, the force of infection is given by:
where b is the per partnership transmission probability and c r is the sexual partner change rate for individuals of sexual activity group r.
The elements of the sexual mixing matrix
describe the conditional probability that an individual of sex s, subpopulation/canton k and sexual activity group r has a sexual contact with an individual of the opposite sex s 0 , sub-population/canton k 0 and sexual activity group r 0 . k and r are the sexual mixing coefficients with respect to sub-population/canton and sexual activity group, respectively. A value of 1 represent fully assortative mixing where individuals only have sexual contacts with other individuals from the same sub-population/canton or sexual activity group. A value of 0 corresponds to proportional (random) mixing where sexual partners are chosen in proportion to the size of their subpopulation/canton and their sexual activity group. d kk 0 and d rr 0 are the Kronecker deltas, which are equal to 1 if k ¼ k 0 or r ¼ r 0 and to 0 otherwise. In the first scenario (assortative sexual mixing), we set k ¼ 1. In the second scenario (proportional sexual mixing), we set k to 0.6 (model with two sub-populations) and 0.8 (cantonal model). Throughout all simulations, we set r ¼ 0:5, which corresponds to partially assortative mixing with respect to sexual activity [26, 22] .
Mobility-informed sexual mixing
We used mobility data as a proxy for inter-cantonal sexual mixing. We assumed that the heterosexual partner preference across cantons is proportional to the corresponding commuting patterns. The symmetrical matrix P mob provides absolute numbers of commuters between cantons without specifying the commuters' canton of residence. We converted P mob into an asymmetrical inter-cantonal mixing matrix r kk 0 that provides the conditional probabilities that a sexual contact from an individual from canton k occurs with someone from canton k 0 . To this end, we first rescaled P mob by a scaling factor s and weighted all columns with the inverse of the cantonal population size:
We then replaced the diagonal entries of r kk 0 with the sum of all entries that are outside canton k:
The force of infection for the mobility-informed sexual mixing scenario is given by Eq. (6) with q ss 0 kk 0 rr 0 being replaced by r kk 0 q ss 0 rr 0 . We chose the scaling factor s such that the weighted proportion of intra-cantonal heterosexual contacts across all cantons is 80% (Supplementary Material Fig. S2 ), i.e., is the same as in the proportional sexual mixing scenario:
Model simulations
We simulated the different model scenarios by numerically integrating the ODEs until the system approached the endemic pre-vaccination equilibrium (p sk ¼ 0). We then initiated the HPV vaccination program by setting p sk > 0, and ran the model for a further number of years. The ODEs were solved in the R software environment for statistical computing [33] using the function ode from the package deSolve. We calculated the basic reproduction number (R 0 ) using the next-generation matrix method as described by Diekmann et al. [34, 35] (Supplementary Material Section 1). This allowed us to compute the vaccination threshold V C ¼ 1À1=R 0 ve . Model simulations were performed on UBELIX (http://www.id.unibe.ch/ hpc), the high performance computing (HPC) cluster at the University of Bern. All code files can be downloaded from GitHub (https://github.com/mauraner/HPV-regional-vaccine-heterogeneitymodel).
Uncertainty analysis
In addition to our baseline scenario, we investigated the robustness of our results taking into account the uncertainty around critical parameters. We used a set of 1,000 different parameter combinations, based on the intervals provided in Table 1 . For the sexual behavior parameters (n l ; n h ; c l ; c h ), we randomly drew from a normal distribution with the corresponding 95% confidence interval (CI). HPV-related parameters (b; c; x; v e ) were chosen uniformly within the corresponding 95% posterior intervals (PI) or CI.
Finally, we randomly selected the parameters m and r from a uniform distribution between 0 and 1. We conducted the uncertainty analysis with the sub-set of 858 parameter combinations that resulted in a non-zero prevalence (> 0:01%). 3. Results
HPV-16 dynamics
Using the parameters from Table 1 , the transmission model provides a realistic description of the HPV-16 dynamics in Switzerland. The baseline parameters result in a model-based estimate of the pre-vaccination prevalence of HPV-16 of 3.34% among 18-24 year olds (median: 3.58%, interquartile range, IQR: 1.54-7.50%, based on uncertainty analysis). While this is somewhat lower than the expected and observed HPV-16 prevalence in Britain (Supplementary Material Section 2, Table S3 ), it is in the range typically observed among women in other European countries [23] . The functional relationship between vaccination coverage and the reduction in HPV-16 prevalence 2 to 4 years post-vaccination is in good agreement with the findings of a systematic review (Supplementary Material Section 3, Fig. S3 ) [3] . The basic reproduction number, R 0 , of HPV-16 in our model is 1.29 (median: 1.42, IQR: 1.08-1.96). This corresponds to a vaccination threshold of 23.5% (median: 34.4%, IQR: 14.2%-53.8%) in the general population. If vaccination targets only one sex, the threshold increases to 41.7% (median: 57.6%, IQR: 26.5-80.5%).
Vaccination in two sub-populations
To better understand the effects of spatially heterogeneous vaccination uptake on infection transmission, we focused on a simplified model with two sub-populations of the same size. We calculated the expected HPV-16 prevalence after 15 years of vaccinating the two sub-populations at different coverage rates (Fig. 3) . In the first scenario, we assumed fully assortative sexual mixing between the two sub-populations, i.e., sexual contacts only occur between individuals from the same sub-population (Fig. 3a) . The concave relation between vaccination coverage in the two sub-populations and the expected prevalence of HPV-16 overall indicates that homogeneous vaccination uptake typically has the largest effect on reducing prevalence. For example, a vaccination coverage of 25% in both sub-populations results in a lower prevalence than vaccinating either of them at 50%. In the second scenario, we assumed a certain level of proportional mixing where 20% of sexual contacts are made with individuals from the other sub-population (Fig. 3b) . Sexual mixing between the two sub-populations diminishes the negative effect of heterogeneous vaccination uptake, but homogeneous vaccination still results in the lowest prevalence of HPV-16. Fig. 3c shows the difference in the expected HPV-16 prevalence between the first (no sexual mixing between the sub-populations) and second (sexual mixing between the sub-populations) scenario. The higher the difference, the stronger the effect of sexual mixing is in reducing the negative consequences of heterogeneous vaccination uptake. In contrast to this short-term scenario (15 years), the effect of sexual mixing can change slightly after extreme long time periods (Supplementary Material Fig. S4 ). Then, sexual mixing can slightly increase the negative consequences of heterogeneous uptake when coverage is below the vaccination threshold in both populations. However, we do not consider this scenario relevant for HPV. In summary, these results illustrate that, in the short-term, spatially heterogeneous vaccination uptake diminishes the effect of vaccination on reducing HPV-16 prevalence, but that sexual mixing between sub-populations can limit these undesired consequences by 'homogenizing' the overall population. Fig. 2 . Chord diagrams of inter-cantonal sexual mixing. The diagrams show the number of sexual contacts between individuals from different cantons. For the scenarios where sexual mixing between cantons occurs (proportional and mobilityinformed sexual mixing), we excluded the sexual contacts between individuals that reside in the same canton for better visibility. Cantons with a French-, German-or Italian-speaking majority are indicated in blue, beige and red, respectively. Acronyms for canton names are explained in the Supplementary Material Table S1.
Transmission of HPV-16 within and between cantons
We extended our analysis of heterogeneous vaccination uptake by simulating the transmission of HPV-16 within and between the 26 cantons of Switzerland. The observed dynamics generalize some of the insights from the simplified model with two subpopulations. After vaccination is introduced, HPV-16 prevalence begins to diverge across cantons (Fig. 4) . After 15 years of vaccination, the range of expected HPV-16 prevalences depends on the assumed scenario for sexual mixing between cantons (see Methods). Assuming baseline parameters and fully assortative mixing, the highest and lowest prevalence are 2.20% (ZG, 17% vaccination coverage) and 0.17% (VS, 75% vaccination coverage), respectively (Fig. 4a) . The range of cantonal HPV-16 prevalence narrows if sexual mixing between cantons is taken into account. The cantonal prevalence ranges from 1.38% to 0.30% for proportional mixing (Fig. 4b) , and from 1.20% to 0.20% for mobility-informed mixing (Fig. 4c) . Thus, sexual mixing between cantons 'homogenizes' the infection dynamics and the effect of vaccination on reducing prevalence.
This homogenizing effect is also reflected in the overall prevalence of HPV-16 in Switzerland. The national prevalence of HPV-16 is slightly higher under heterogeneous vaccination uptake compared with homogeneous uptake (Fig. 4) . This difference becomes smaller in the two scenarios that assume sexual mixing between the two cantons ( Fig. 4b and c) . In the most realistic scenario (mobility-informed mixing), the national prevalence of HPV-16 is expected to drop to 0.55% after 15 years of heterogeneous vaccination uptake, while homogeneous vaccination uptake would drop the prevalence to 0.49%. Additional analyses illustrate that the result of heterogeneous vaccination uptake, yielding a slightly higher HPV-16 prevalence compared with homogeneous uptake, is robust with respect to parameter uncertainty (Fig. 4 , righthand panels), and different assumptions about sexual mixing, sexual activity, cantonal population sizes and the overall vaccination uptake (Supplementary Material Table S4 ).
Inter-cantonal sexual mixing helps to reduce the prevalence of HPV-16 in cantons with low vaccination coverage at the expense of cantons with high vaccination coverage. At the national level, increasing sexual mixing between cantons always results in a lower HPV-16 prevalence (Fig. 5, dashed red lines) , while the effect of sexual mixing at the cantonal level is more nuanced. The number of cantons that achieve a specific reduction in prevalenceexpressed as relative risk (RR) reduction -can either decrease or increase with varying degrees of sexual mixing (Fig. 5) . For example, high levels of sexual mixing between cantons (low k ) increase the number of cantons that achieve a 50% reduction in prevalence after 15 years of vaccination (Fig. 5a ). In contrast, low levels of sexual mixing between cantons (high k ) are required to increase the number of cantons that achieve a RR reduction of 90%. In the longterm (50 years of vaccination), the number of cantons that reach a RR reduction of 99% is lowest for low-but realistic-levels of sexual mixing between cantons ( k ¼ 0:80 À 0:95) (Fig. 5b) . These levels of sexual mixing prevent the elimination of HPV-16 in highcoverage cantons, but they are too low for low-coverage cantons to sufficiently benefit from the herd immunity of high-coverage cantons.
Discussion
Uptake of HPV vaccination in 16 year old girls in Switzerland shows pronounced differences between different cantons ranging from 17 to 75%. We used a dynamic transmission model to study the expected consequences of this spatial heterogeneity in vaccination uptake on the transmission and prevalence of HPV-16 in Switzerland. Using a simple model with two sub-populations, we found that heterogeneous vaccination uptake can diminish the effect of vaccination on reducing HPV-16 prevalence in the overall population. This effect is strongest when vaccination is very heterogeneous, i.e., when uptake is very high in one subpopulation and very low in the other sub-population. These results were corroborated with an extended model simulating the trans- mission of HPV-16 within and between the 26 cantons of Switzerland. Homogeneous vaccination uptake would generate a lower national HPV-16 prevalence compared to heterogeneous vaccination uptake, but the overall differences in prevalence are very small. We found that inter-cantonal sexual mixing 'homogenizes' the infection dynamics, limits the undesired consequences of heterogeneous vaccination uptake, and reduces the intercantonal differences in HPV-16 prevalence. The example of Switzerland provides sufficient data for parameterizing a dynamic transmission model while exhibiting large variation in HPV-16 vaccine deployment. Using Swiss sexual behavior data, the model provided a realistic description of HPV-16 transmission in Switzerland, and allowed us to investigate the expected effect of HPV vaccination. Our finding that homogeneous vaccination uptake between cantons would help reduce HPV-16 prevalence in Switzerland does not change qualitatively when the number of cantons or parameter values are varied within reasonable ranges. In the absence of data describing inter-cantonal sexual mixing in Switzerland, we used commuting data and explored three different scenarios. The two scenarios that assumed partial sexual mixing between cantons -proportional sexual mixing and mobility-informed mixing -gave rise to a similar pattern, strengthening the validity of our findings.
Our study has a number of limitations that need be considered when interpreting the findings. First, we used a relatively simple compartmental model to describe the transmission of HPV-16, not taking into account potential sex-specific differences in sexual behavior and the natural history of infection. Even though we accounted for heterogeneity in sexual behavior with two different sexual activity groups, the compartmental structure of the model implicitly assumes homogeneous mixing within these subgroups, i.e., we do not account for specific sexual networks. Further, we did not consider different age classes and assumed that women can only become vaccinated before the age of 18. We also assumed a closed population without a possible influx or efflux of virus from or to younger and older age groups. These simplifying assumptions could affect our model-based estimate of HPV-16 prevalence. Owing to our focus on the transmission and prevalence of HPV-16, we did not include other high risk HPV types, as some modeling studies have done [9, 30, 10, 31] . Our results depend on the assumption that sexual behavior and the subsequent risk of HPV infection are the same across different cantons. Second, comparison of HPV-16 prevalence and the sexual behavior data (i.e., the estimated heterosexual partner change rates) between Swiss and British women needs to be treated with caution. Although the particular question about the number of new heterosexual partners was the same in both surveys, the methods for sampling and data collection differed considerably. While the Swiss SIR survey interviewed participants by phone, the British National Survey of Sexual Attitudes and Lifestyles (Natsal-3) relied on individuals completing questionnaires at the participants' homes. This difference could have introduced a social desirability bias that could result in an underestimation of heterosexual partner changes in the SIR study. This underestimation might be further compounded by the fact that the SIR survey included only women. Given the sensitivity of our model with regard to per partnership transmission probabilities (Supplementary Material Fig. S5 ) and heterosexual partner change rates, our calculations of R 0 and the corresponding vaccination thresholds should be interpreted carefully. Third, in absence of data about the levels of sexual mixing between cantons, we assumed that inter-cantonal sexual mixing is proportional to the observed commuting patterns. We also assumed that the national average of sexual contacts that are made with individuals from the same canton is 80%, and that 20% are made with individuals from another canton. This assumption was informed by a 1981 Canadian study on couple composition regarding language (French, English or other) [36] . On average, 18.2% of couples in Quebec were exogamous, with some heterogeneity over different regions. Fourth, besides inter-cantonal variation in HPV vaccination uptake, there is also intra-cantonal variation. For example, vaccination uptake in Geneva, which has The graphs show the number of cantons that achieve a specific relative risk (RR) reduction after vaccination in the shortterm (15 years, a) and longterm (50 years, b). The dashed red lines correspond to the national prevalence which is lowest if sexual mixing is highest, i.e., completely proportional ( k ¼ 0), between cantons. For all simulations, we used the proportional sexual mixing scenario. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) a school-based vaccination program, varies significantly according to nationality and socio-economic status [37] . Investigating the causes and consequences of intra-cantonal variation in HPV vaccination uptake in Switzerland is part of ongoing work.
There are currently no population-based prevalence estimates of type-specific HPV in Switzerland. Our modeled pre-vaccination prevalence of HPV-16 is 3.34%, and is within a plausible range for women in European countries [23] . A meta-analysis of more than 1 million women estimated HPV-16 prevalence at 4.8% and 3.2% in Europe and globally, respectively [23] . Only a few studies provide estimates for the basic reproduction number, R 0 , or equivalently, the vaccination threshold of HPV-16 or other HPV types. Ribassin-Majed et al. [38] estimated R 0 ¼ 1:73 for HPV-16/18 in France, corresponding to a vaccination threshold of 67% for one sex. These values are higher than we calculated for Switzerland, but lie in a similar range to those expected in Britain (Supplementary Material Table S3 ). The lower values that we calculated for Switzerland underline the possibility of underreporting in the Swiss sexual behavior survey.
Our results need to be interpreted in the context of the literature considering heterogeneity in HPV vaccination. The finding that decreasing heterogeneity in vaccination uptake increases impact helps to interpret the result by Durham et al. [18] who showed that vaccination efforts should be targeted towards lowvaccination states in the USA. Increasing vaccination uptake in populations with low-vaccination uptake has the strongest effect for reducing vaccination heterogeneity overall. The study by Shafer et al. [19] on unequal HPV vaccination uptake among different ethnic groups in Canada, suggests that heterogeneous vaccination can lead to cross-over effects across groups and depends on the amount of sexual mixing between the groups. Our study supports these findings and illustrates the effect of heterogeneous vaccination uptake between different populations and its relationship with different amounts of sexual mixing between them.
While reducing cantonal variation in vaccination uptake would help further reduce HPV-16 prevalence in Switzerland, the expected additional effect would be small. This finding occurred despite vaccination uptake below the model-based estimate of vaccination threshold (47.7%) in ten cantons (ZG, AR, SZ, OW, AI, TG, BE, TI, SH and UR). Assuming homogeneous vaccination at the same overall level, all cantons would have a vaccination coverage of 52% (national average) and would therefore be above the threshold. One might intuitively expect that the effects of herd immunity in the latter scenario would result in a substantially lower prevalence of HPV-16 compared with heterogenous uptake, which was not the case in our model simulations. One explanation for this observation is that we compared the short-term effects of vaccination after 15 years, when prevalence was still declining rapidly in all cantons and the effects of herd immunity are not fully active.
Our findings could have implications for the future planning of HPV vaccination programs at the cantonal and national level in Switzerland. From the point of view of a particular canton, the achieved reduction in HPV-16 prevalence will not only depend on the cantonal vaccination program, but also on the indirect effects of vaccination efforts in other (particularly neighboring) cantons and how these effects are dissipated via intra-cantonal sexual mixing. For the most plausible scenario for inter-cantonal mixing (mobility-informed sexual mixing), we found that cantons with high vaccination coverage experience a less effective reduction in HPV-16 prevalence to what would be expected if they were isolated (assortative sexual mixing). This effect benefits cantons with a low vaccination uptake that achieve a higher reduction in prevalence than expected in the absence of intra-cantonal sexual mixing. The intensity of cantonal dissipation of vaccination efforts is again mediated by intra-cantonal sexual mixing. The number of cantons that surpass a pre-defined relative risk reduction is highly sensitive to the level of assortative mixing between cantons (Fig. 5) . The results of this study suggest that a harmonization of programs between cantons, and a reduction in vaccination heterogeneity, would result in a stronger effect of vaccination on reducing HPV-16 prevalence in Switzerland. The generalizability of our results on the effects of spatial heterogeneity in vaccination uptake could also be of relevance for the planning of prevention strategies for other STIs that exhibit similar transmission dynamics. Increasing HPV vaccination uptake in males would help reducing overall vaccine targeted HPV infection levels, but more modeling studies are needed to estimate the impact of male uptake by both sex and geography [15, 39, 17] .
In summary, we found that spatial heterogeneity in HPV vaccination uptake is expected to diminish the effect of vaccination on HPV-16 prevalence, but the overall effect is small. In Switzerland, although the expected impact on national prevalence would be relatively small, harmonization of cantonal vaccination programs would reduce inter-cantonal differences in HPV-16 prevalence.
